I spent most of my career working with antibodies and the development of antibody drugs...... It's usually a very slow methodical process. Taking something from the lab to the clinic trial stage generally takes years. Last clinical trial out of my lab to a lot of years......
Getting around clinical or taking short cuts in clinical is is a really bad idea.
Speeding up/weeding out stuff to get to clinical is where you have the ability to save time. Even something like IBM's Watson can help correlate disparate data sets and lead to potential new insights/paths. The number and type of in vitro tests can be streamlined and possibly an earlier and more focused in-vivo. If there is money available those could be run in parallel or near parallel.
Stuff that looked good in vitro or even in vivo often falls apart in clinical because the side effects are so unpredictable. I find it amusing that a fair number of drugs being marketed today were never intended for treating the maladies they are treating. They were originally intended for something completely different. The clinical's uncovered side effects that were able to "fix" something. Silver lining!
